Damien Vasseur

597 total citations
38 papers, 106 citations indexed

About

Damien Vasseur is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Damien Vasseur has authored 38 papers receiving a total of 106 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Cancer Research, 19 papers in Pulmonary and Respiratory Medicine and 17 papers in Oncology. Recurrent topics in Damien Vasseur's work include Cancer Genomics and Diagnostics (21 papers), Lung Cancer Treatments and Mutations (13 papers) and Radiomics and Machine Learning in Medical Imaging (6 papers). Damien Vasseur is often cited by papers focused on Cancer Genomics and Diagnostics (21 papers), Lung Cancer Treatments and Mutations (13 papers) and Radiomics and Machine Learning in Medical Imaging (6 papers). Damien Vasseur collaborates with scholars based in France, Spain and United States. Damien Vasseur's co-authors include Benjamin Besse, Antonin Lévy, Étienne Rouleau, David Planchard, Antoine Hollebecque, Cristina Smolenschi, Antoîne Italiano, Jordi Remón, Pernelle Lavaud and Ludovic Lacroix and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Damien Vasseur

30 papers receiving 103 citations

Peers

Damien Vasseur

PRM

ONCOL

SURGE

Hwei-Chung Wang Taiwan

Iolanda Capone Italy

Pradeep Bose United Kingdom

Bangxian Tan China

Lisa Kinget Belgium

Sander Bach Netherlands

Brian Hunis United States

Kate Weiss United States

Masaki Sunagawa Japan

Birutė Brasiūnienė Lithuania

Hwei-Chung Wang Taiwan

Damien Vasseur

33 ×0.7

PRM

71 ×1.6

ONCOL

47 ×1.2

31 ×0.9

SURGE

41 ×1.3

Citations per year, relative to Damien Vasseur Damien Vasseur (= 1×) peers Hwei-Chung Wang

Countries citing papers authored by Damien Vasseur

Since Specialization

Citations

This map shows the geographic impact of Damien Vasseur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Damien Vasseur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Damien Vasseur more than expected).

Fields of papers citing papers by Damien Vasseur

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Damien Vasseur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Damien Vasseur. The network helps show where Damien Vasseur may publish in the future.

Co-authorship network of co-authors of Damien Vasseur

This figure shows the co-authorship network connecting the top 25 collaborators of Damien Vasseur. A scholar is included among the top collaborators of Damien Vasseur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Damien Vasseur. Damien Vasseur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Facchinetti, Francesco, Yohann Loriot, Floriane Brayé, et al.. (2024). Understanding and Overcoming Resistance to Selective FGFR Inhibitors across FGFR2 -Driven Malignancies. Clinical Cancer Research. 30(21). 4943–4956. 17 indexed citations

Blanc‐Durand, Félix, Damien Vasseur, Audrey Le Formal, et al.. (2024). An evaluation of cell-free tumor DNA from 20 mL of peritoneal fluid for homologous recombination deficiency (HRD) testing in newly diagnosed ovarian cancer (OC).. Journal of Clinical Oncology. 42(16_suppl). 5577–5577. 1 indexed citations

Tagliamento, Marco, Damien Vasseur, Jordi Remón, et al.. (2024). Circulating tumor DNA to guide diagnosis and treatment of localized and locally advanced non-small cell lung cancer. Cancer Treatment Reviews. 129. 102791–102791. 13 indexed citations

Parisi, Claudia, Damien Vasseur, Pernelle Lavaud, et al.. (2024). Personalized Therapy in a Patient With EGFR-Mutated NSCLC Developing Sequential CCDC6-RET Fusion and BRAF V600E Mutation as Bypass Resistance Mechanisms. JTO Clinical and Research Reports. 6(3). 100773–100773.

Blanc‐Durand, Félix, Géraldine M. Camilleri, Arnaud Bayle, et al.. (2024). Clinical utility of comprehensive liquid molecular profiling in patients with advanced endometrial cancer. Cancer. 130(19). 3311–3320. 1 indexed citations

Vasseur, Damien, Odile Cabaret, Sophie Cotteret, et al.. (2024). Case report: Microsatellite instability determination is not always black and white in Lynch syndrome diagnosis. Frontiers in Oncology. 14. 1396869–1396869. 1 indexed citations

Dall’Olio, Filippo Gustavo, Damien Vasseur, Maryam Karimi, et al.. (2023). Association of ctDNA tumor fraction with survival in advanced non-small cell lung cancer (NSCLC) treated with maintenance durvalumab in the UNICANCER SAFIR02-Lung/IFCT1301 trial.. Journal of Clinical Oncology. 41(16_suppl). 2516–2516.

Zullo, Lodovica, Maria‐Rosa Ghigna, Damien Vasseur, et al.. (2023). 80P Tumor microenvironment (TME) defines prognosis of EGFR-mutant non-small cell lung cancer (NSCLC). ESMO Open. 8(1). 101890–101890. 1 indexed citations

Smolenschi, Cristina, Antoine Hollebecque, Alice Boilève, et al.. (2023). PD-29 Could molecular profiling be helpful in daily practice in the treatment of anal carcinoma?. Annals of Oncology. 34. S13–S13. 1 indexed citations

10.

Smolenschi, Cristina, Antoine Hollebecque, Damien Vasseur, et al.. (2023). 1659P The use of liquid biopsy in patients with advanced pancreatic cancer (PDAC) to guide enrollment in phase I clinical trials. Annals of Oncology. 34. S913–S914. 1 indexed citations

11.

Blanc‐Durand, Félix, Christopher M. Kramer, Etienne Rouleau, et al.. (2023). 788P Molecular profiling of p53 mutant endometrial cancer reveals distinct subgroups with opportunities for personalized therapeutic approaches. Annals of Oncology. 34. S529–S530.

12.

Blanc‐Durand, Félix, Damien Vasseur, Audrey Le Formal, et al.. (2023). Homologous recombination deficiency (HRD) testing on cell-free tumor DNA from peritoneal fluid. Molecular Cancer. 22(1). 178–178. 4 indexed citations

13.

Ghigna, Maria‐Rosa, J. Remon Masip, Damien Vasseur, et al.. (2023). 1334P Activity of first line immunotherapy or chemo-immunotherapy in advanced NSCLC with SMARCA4 deficiency. Annals of Oncology. 34. S769–S769. 2 indexed citations

14.

Bayle, Arnaud, Damien Vasseur, Claudio Nicotra, et al.. (2023). Clinical utility of plasma ctDNA sequencing in metastatic urothelial carcinoma.. Journal of Clinical Oncology. 41(16_suppl). 4576–4576. 1 indexed citations

15.

Ammari, Samy, Damien Vasseur, Fremont P. Wirth, et al.. (2023). 142P Correlating total tumor volume on CT-Scan and liquid biopsy ctDNA in 1017 patients with metastatic cancer: A novel study. Annals of Oncology. 34. S237–S237. 1 indexed citations

16.

Vasseur, Damien, Alice Boilève, Cristina Smolenschi, et al.. (2023). Targetable Molecular Alterations in the Treatment of Biliary Tract Cancers: An Overview of the Available Treatments. Cancers. 15(18). 4446–4446. 16 indexed citations

17.

Riudavets, Mariona, Damien Vasseur, Édouard Auclin, et al.. (2022). Clinical Utility and Outcomes Impact of Crystal Digital PCR of Sensitizing and Resistance EGFR Mutations in Patients With Advanced Non-Small Cell Lung Cancer. Clinical Lung Cancer. 23(6). e377–e383. 1 indexed citations

18.

Aldea, Mihaela, Claudia Parisi, Luigi Cerbone, et al.. (2021). 1344P Molecular features of young cannabis smokers with advanced non-small cell lung cancer (aNSCLC). Annals of Oncology. 32. S1024–S1025. 3 indexed citations

19.

Facchinetti, Francesco, Antonin Lévy, Samy Ammari, et al.. (2021). Meningeal “Lazarus Response” to Lorlatinib in a ROS1-Positive NSCLC Patient Progressing to Entrectinib. Cancer Management and Research. Volume 13. 2805–2810. 9 indexed citations

20.

Géraud, Arthur, Laura Mezquita, Édouard Auclin, et al.. (2020). Chronic Plasma Exposure to Kinase Inhibitors in Patients with Oncogene-Addicted Non-Small Cell Lung Cancer. Cancers. 12(12). 3758–3758. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact